Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results
· manilatimes.net
New data presented at Digestive Disease Week (DDW) demonstrating improvement of fibrosis and inflammation following a single treatment of EP-104GI
New data presented at Digestive Disease Week (DDW) demonstrating improvement of fibrosis and inflammation following a single treatment of EP-104GI
Strengthened...